HomeInsightsStock Comparison

Akums Drugs Pharmaceuticals Ltd vs Sun Pharmaceuticals Industries Ltd Stock Comparison

Akums Drugs Pharmaceuticals Ltd vs Sun Pharmaceuticals Industries Ltd Stock Comparison

Last Updated on: May 06, 2025

Key Highlights

  • The Latest Trading Price of Akums Drugs & Pharmaceuticals Ltd is ₹ 510.2 as of 06 May 15:30.
  • The P/E Ratio of Akums Drugs & Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 22.5 on March 2020 to 40.6 on March 2024 . This represents a CAGR of 12.53% over 5 years.
  • The Market Cap of Akums Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 84504 crore on March 2020 to ₹ 388812 crore on March 2024 . This represents a CAGR of 35.70% over 5 years.
  • The revenue of Akums Drugs & Pharmaceuticals Ltd for the Dec '24 is ₹ 1029 crore as compare to the Sep '24 revenue of ₹ 1050 crore. This represent the decline of -1.95% The revenue of Sun Pharmaceutical Industries Ltd for the Dec '24 is ₹ 14141 crore as compare to the Sep '24 revenue of ₹ 13645 crore. This represent the growth of 3.63%.
  • The ebitda of Akums Drugs & Pharmaceuticals Ltd for the Dec '24 is ₹ 140.71 crore as compare to the Sep '24 ebitda of ₹ 138.35 crore. This represent the growth of 1.71% The ebitda of Sun Pharmaceutical Industries Ltd for the Dec '24 is ₹ 4158 crore as compare to the Sep '24 ebitda of ₹ 4292 crore. This represent the decline of -3.13%.
  • The net profit of Akums Drugs & Pharmaceuticals Ltd changed from ₹ -187 crore to ₹ 66.31 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2013 crore to ₹ 2917 crore over 7 quarters. This represents a CAGR of 23.62% .
  • The Dividend Payout of Akums Drugs & Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 29.89 % on March 2020 to 113.33 % on March 2024 . This represents a CAGR of 30.55% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Akums Drugs & Pharmaceuticals Ltd

  • Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the RoC. Alkums Drugs & Pharmas are a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
  • They are into sale of branded pharmaceutical formulations and manufacturing of Active Pharmaceutical Ingredients.
  • Some of the other services include formulation research and development, preparation and filing of regulatory dossiers into the Indian and global markets, and other testing services.
  • Some of manufacturing units have been accredited by various global regulatory agencies such as the European Good Manufacturing Practice, the World Health Organization Good Manufacturing Practice and the United States National Sanitation Foundation.

About Sun Pharmaceutical Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Akums Drugs & Pharmaceuticals Ltd News Hub

News

Akums Drugs & Pharmaceuticals to table results

Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

01 Feb 2025 17:13

News

Akums Drugs drops as IT dept conducts search at its offices & units

'Income Tax Department conducted search under the Income Tax Act, 1961 at the offices and ...

Read more

22 Jan 2025 12:07

News

Akums Drugs rallies on inking pact to supply pharmaceutical formulations in Europe

The agreement is in line with Akums growth objective of expanding in European and other re...

Read more

24 Dec 2024 13:01

News

Akums Drugs ties up with Jagdale Inds for marketing of ready-to-drink nutritional beverages

This collaboration exclusively focuses on aseptic manufacturing and subsequent filling in ...

Read more

26 Nov 2024 12:47

News

Akums Drugs hits life high on inking pact with Caregen

Under the agreement, Akums was granted exclusive rights to sell a selection of Caregen's p...

Read more

19 Nov 2024 12:59

News

Akums Drugs & Pharmaceuticals to conduct board meeting

Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

06 Nov 2024 15:48

Sun Pharmaceutical Industries Ltd News Hub

News

Sun Pharma and Israel-based Moebius Medical publish two articles on MM-II

Sun Pharmaceutical Industries and Israel-based Moebius Medical announced today the publica...

Read more

24 Apr 2025 09:12

News

Sun Pharmaceutical launches Fexuprazan tablets 40 mg in India

Sun Pharmaceutical Industries has launched Fexuprazan tablets 40 mg in India under the bra...

Read more

07 Apr 2025 09:07

News

Sun Pharma launches Fexuprazan tablets 40 mg in India

The drug, available in 40 mg tablets, is approved as a new treatment for adults with erosi...

Read more

07 Apr 2025 10:23

News

Sun Pharma completes acquisition of Antibe Therapeutics Inc., Canada

Sun Pharmaceutical Industries has completed 100% acquisition of Antibe Therapeutics Inc., ...

Read more

18 Mar 2025 15:01

News

Sun Pharma gains as arm acquires Antibe Therapeutics for $4.5 Million

Sun Pharmaceuticals Industries is a leading global pharmaceutical company with a specialty...

Read more

18 Mar 2025 12:53

News

Sun Pharmaceuticals Industries Ltd soars 0.96%, gains for fifth straight session

Sun Pharmaceuticals Industries Ltd rose for a fifth straight session today. The stock is q...

Read more

17 Mar 2025 13:00

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Akums Drugs & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharmaceutical Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Akums Drugs & Pharmaceuticals Ltd and Sun Pharmaceutical Industries Ltd

Which company has a larger market capitalization, Akums Drugs & Pharmaceuticals Ltd or Sun Pharmaceutical Industries Ltd?

Market cap of Akums Drugs & Pharmaceuticals Ltd is 8,030 Cr while Market cap of Sun Pharmaceutical Industries Ltd is 436,379 Cr

What are the key factors driving the stock performance of Akums Drugs & Pharmaceuticals Ltd and Sun Pharmaceutical Industries Ltd?

The stock performance of Akums Drugs & Pharmaceuticals Ltd and Sun Pharmaceutical Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Akums Drugs & Pharmaceuticals Ltd and Sun Pharmaceutical Industries Ltd?

As of May 6, 2025, the Akums Drugs & Pharmaceuticals Ltd stock price is INR ₹510.2. On the other hand, Sun Pharmaceutical Industries Ltd stock price is INR ₹1818.75.

How do dividend payouts of Akums Drugs & Pharmaceuticals Ltd and Sun Pharmaceutical Industries Ltd compare?

To compare the dividend payouts of Akums Drugs & Pharmaceuticals Ltd and Sun Pharmaceutical Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions